Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 11/20 | 0.47 |
| ▸ | CNR1 | P21554 | 8/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3990809 | 0.91 | CNR2 (0.60) | CNR2CNR1 | |
| SCHEMBL3972624 | 0.84 | POLB (0.55) | NR4A2LMNAALDH1A1SMN1; SMN2KMT2A | |
| SCHEMBL3995883 | 0.84 | CNR2 (0.55) | CNR2CNR1LMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL13806412 | 0.84 | CNR2 (0.47) | CNR2CNR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL3981980 | 0.84 | CNR1 (0.56) | CNR2CNR1LMNASMN1; SMN2L3MBTL1 | |
| SCHEMBL3990432 | 0.82 | CNR2 (0.53) | CNR2CNR1 | |
| SCHEMBL3975404 | 0.82 | CREBBP (0.45) | ALDH1A1KMT2APOLB | |
| SCHEMBL3993831 | 0.81 | NTRK1 (0.42) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL3986991 | 0.81 | CNR2 (0.47) | CNR2CNR1 | |
| SCHEMBL3980644 | 0.80 | ALDH1A1 (0.48) | CNR2CNR1LMNAALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2065382-A1 | CGRP antagonists | Boehringer Ingelheim Pharma GmbH & Co. KG (DE) | 2009-06-03 | — | — | EP | disclosed |
| WO-2009050235-A1 | CGRP ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-04-23 | — | — | WO | disclosed |